We are live on ! Find out more
CA

Crewe Advisors Portfolio holdings

AUM $1.38B
1-Year Est. Return 41.76%
This Fund
S&P 500
This Quarter Est. Return
-2.18%
1 Year Est. Return
+41.76%
3 Year Est. Return
+96.1%
5 Year Est. Return
+98.15%
10 Year Est. Return
AUM
$712M
AUM Growth
-$13.7M
Cap. Flow
+$11.2M
Cap. Flow %
1.57%
Top 10 Hldgs %
60.79%
Holding
765
New
119
Increased
141
Reduced
110
Closed
49

Sector Composition

Rank Sector Weight
1 Financials 8.55%
2 Technology 4.36%
3 Healthcare 2.88%
4 Consumer Discretionary 2.35%
5 Energy 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXT icon
676
Textron
TXT
$14.2B
$289 ﹤0.01%
4
OC icon
677
Owens Corning
OC
$11.6B
$286 ﹤0.01%
2
LPX icon
678
Louisiana-Pacific
LPX
$5.04B
$276 ﹤0.01%
+3
New +$313
BC icon
679
Brunswick
BC
$5.19B
$270 ﹤0.01%
5
CQQQ icon
680
Invesco China Technology ETF
CQQQ
$3.01B
$266 ﹤0.01%
+6
New +$264
AYI icon
681
Acuity Brands
AYI
$10.1B
$264 ﹤0.01%
1
CRWV
682
CoreWeave
CRWV
$48.3B
$260 ﹤0.01%
+7
New +$270
EOG icon
683
EOG Resources
EOG
$77B
$257 ﹤0.01%
2
-154
-99% -$19.8K
SG icon
684
Sweetgreen
SG
$819M
$251 ﹤0.01%
10
BLDR icon
685
Builders FirstSource
BLDR
$7.41B
$250 ﹤0.01%
2
HOLX
686
DELISTED
Hologic
HOLX
$248 ﹤0.01%
4
IVZ icon
687
Invesco
IVZ
$14.6B
$243 ﹤0.01%
16
ASH icon
688
Ashland
ASH
$3.38B
$238 ﹤0.01%
4
TPG icon
689
TPG
TPG
$8.82B
$238 ﹤0.01%
5
DKNG icon
690
DraftKings
DKNG
$12.3B
$233 ﹤0.01%
7
NBIX icon
691
Neurocrine Biosciences
NBIX
$15.7B
$222 ﹤0.01%
2
BBY icon
692
Best Buy
BBY
$18.5B
$221 ﹤0.01%
3
XYLD icon
693
Global X S&P 500 Covered Call ETF
XYLD
$3.29B
$218 ﹤0.01%
6
+1
+20% +$42
CIM
694
Chimera Investment
CIM
$959M
$206 ﹤0.01%
16
JWN
695
DELISTED
Nordstrom
JWN
$196 ﹤0.01%
8
AFRM icon
696
Affirm
AFRM
$25.7B
$181 ﹤0.01%
+4
New +$237
CLOV icon
697
Clover Health Investments
CLOV
$2.21B
$180 ﹤0.01%
50
OGN icon
698
Organon & Co
OGN
$3.61B
$179 ﹤0.01%
12
INSW icon
699
International Seaways
INSW
$4.68B
$166 ﹤0.01%
5
WBX
700
Wallbox
WBX
$69.6M
$164 ﹤0.01%
25

Similar funds

Crewe Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Crewe Advisors held 765 positions worth $712M, down 1.9% from $725M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Crewe Advisors's Q1 2025 filing shows 119 new, 141 increased, 110 reduced and 49 closed positions. Its largest new stake was Aspire Biopharma: 261 shares worth $183K. The largest sale was Berkshire Hathaway Class B, an estimated $6.93M.

By sector, the portfolio is most concentrated in Financials at 8.6% of assets, up from 8.3% a quarter earlier, followed by Technology and Healthcare.

  • Crewe Advisors's largest Q1 2025 buy was Aspire Biopharma: 261 shares worth $183K.
  • Crewe Advisors added most to iShares National Muni Bond ETF in Q1 2025, an estimated $9.71M increase.
  • Crewe Advisors's biggest Q1 2025 reduction was Berkshire Hathaway Class B, cutting an estimated $6.93M.
  • Crewe Advisors fully exited iShares 3-7 Year Treasury Bond ETF in Q1 2025, selling an estimated $754K.
  • Crewe Advisors's ten largest holdings make up 61% of its $712M portfolio in Q1 2025.
  • Crewe Advisors opened 119 new positions and closed 49 in Q1 2025.
  • Crewe Advisors's portfolio value fell 1.9% quarter-over-quarter to $712M.

Based on Crewe Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.